Open Beta
TREN
MetriLume
TREN

US marketsIDXG

SEC-sourced researchBeta

IDXG

INTERPACE BIOSCIENCES, INC.

Company comparison ↗

Data passport

CIK
0001054102
Exchange
OTC
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Oct 1, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 46,926,000.0000 USD; December 2025: 38,728,000.0000 USD46.9M USD0 USD0December 2024December 2025
IDXG · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202446,926,000.0000Mar 30, 2026
December 202538,728,000.0000Mar 30, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202538,728,000.000024,575,000.00005,831,000.000033,838,000.000011,475,000.0000Mar 30, 2026
December 202446,926,000.00006,702,000.00004,646,000.000014,792,000.000017,009,000.0000Mar 30, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$38.73MDecember 2025Mar 30, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$46.93MDecember 2024Mar 30, 202610-K
Net incomeNetIncomeLoss$24.58MDecember 2025Mar 30, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$5.83MDecember 2025Mar 30, 202610-K
Total assetsAssets$33.84MDecember 2025Mar 30, 202610-K
Total liabilitiesLiabilities$11.48MDecember 2025Mar 30, 202610-K

New filings

Explore methodology ↗